Table 2.
Response | No. of Patients (N=35) |
% | Median % Change in Average SUV (range) |
---|---|---|---|
Complete Response | 1 | 3 | −78.8% (n=1) |
Partial Response | 10 | 28 | −10.0% (−0.5 to −22.9) (n=5) |
Stable Disease Total Stable Disease > 6 months |
16 13 |
46 37 |
−13.9% (−34.4 to 11.5) (n=12) |
Progressive Disease | 6 | 17 | 8.6% (−0.8 to 36.1) (n=4) |
Not Assessable | 2 | 6 | n =13 |
Objective Response Rate 95% CI |
11 | 31 (16 to 47) |
|
Disease Control Rate 95% CI |
27 | 77 (63 to 91) |
|
Disease Control by Histology WDTC MTC |
22/28 5/7 |
78 71 |
Abbreviations: CI, Confidence Interval; WDTC, Well-differentiated thyroid cancer; MTC, Medullary thyroid cancer
Disease control rate includes patients with complete response, partial response, and stable disease at 3 months.